Padmavathi Baskar

Array ( [id] => 7783919 [patent_doc_number] => 20120045475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'LIVE ATTENUATED VACCINES' [patent_app_type] => utility [patent_app_number] => 13/202534 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21142 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045475.pdf [firstpage_image] =>[orig_patent_app_number] => 13202534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500627 [patent_doc_number] => 20100215683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'PROTECTIVE ANTIGENS FOR GROUP B STREPTOCOCCUS HYPERVIRULENT STRAINS' [patent_app_type] => utility [patent_app_number] => 12/706387 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 116002 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215683.pdf [firstpage_image] =>[orig_patent_app_number] => 12706387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254165 [patent_doc_number] => 08617574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Nontypable Haemophilus influenzae antigens' [patent_app_type] => utility [patent_app_number] => 13/148695 [patent_app_country] => US [patent_app_date] => 2010-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 61227 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519278 [patent_doc_number] => 20100203057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/704435 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23924 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203057.pdf [firstpage_image] =>[orig_patent_app_number] => 12704435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10098005 [patent_doc_number] => 09134312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Antibacterial phage, phage peptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/148009 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 228 [patent_figures_cnt] => 230 [patent_no_of_words] => 24935 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8532948 [patent_doc_number] => 08309100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strains' [patent_app_type] => utility [patent_app_number] => 12/700432 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12893 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12700432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882764 [patent_doc_number] => 08969529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Methods and compositions based on shiga toxin type 2 protein' [patent_app_type] => utility [patent_app_number] => 13/142556 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 12 [patent_no_of_words] => 18057 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538194 [patent_doc_number] => 08313915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Early detection of canine lyme disease by specific peptides and antibodies' [patent_app_type] => utility [patent_app_number] => 12/690663 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8629 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12690663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766181 [patent_doc_number] => 20120034230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA' [patent_app_type] => utility [patent_app_number] => 13/144149 [patent_app_country] => US [patent_app_date] => 2010-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 60008 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034230.pdf [firstpage_image] =>[orig_patent_app_number] => 13144149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8283056 [patent_doc_number] => 08217159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'BASB082 polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/684830 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 26008 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12684830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561675 [patent_doc_number] => 20100272725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Neisserial antigens' [patent_app_type] => utility [patent_app_number] => 12/653954 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 129075 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272725.pdf [firstpage_image] =>[orig_patent_app_number] => 12653954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591461 [patent_doc_number] => 08349336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Streptococcus pyogenes antigens' [patent_app_type] => utility [patent_app_number] => 12/642361 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 52423 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12642361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652668 [patent_doc_number] => 08372411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'S. pneumoniae antigens' [patent_app_type] => utility [patent_app_number] => 12/637589 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 14 [patent_no_of_words] => 56477 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12637589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024822 [patent_doc_number] => 20110053148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'COCCIDIOSIS VACCINES' [patent_app_type] => utility [patent_app_number] => 12/633426 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7894 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053148.pdf [firstpage_image] =>[orig_patent_app_number] => 12633426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8663995 [patent_doc_number] => 08377455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Biosurfactant composition produced by a new Bacillus licheniforms strain, uses and products thereof' [patent_app_type] => utility [patent_app_number] => 13/131420 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 37 [patent_no_of_words] => 15570 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13131420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328231 [patent_doc_number] => 08236325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'S. epidermidis antigens' [patent_app_type] => utility [patent_app_number] => 12/625053 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29040 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12625053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245692 [patent_doc_number] => 20100136016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'HEAT SHOCK PROTEINS FROM MYCOBACTERIUM LEPRAE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/624288 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13966 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136016.pdf [firstpage_image] =>[orig_patent_app_number] => 12624288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245826 [patent_doc_number] => 20100136046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'RECOMBINANT POLYPROTEIN VACCINES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS' [patent_app_type] => utility [patent_app_number] => 12/621382 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23454 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136046.pdf [firstpage_image] =>[orig_patent_app_number] => 12621382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6371565 [patent_doc_number] => 20100075378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'MORAXELLA CATARRHALIS BASB115 POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/621426 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19478 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075378.pdf [firstpage_image] =>[orig_patent_app_number] => 12621426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280564 [patent_doc_number] => 20100119534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'MULTICOMPONENT IMMUNOGENIC COMPOSITION FOR THE PREVENTION OF BETA-HEMOLYTIC STREPTOCOCCAL (BHS) DISEASE' [patent_app_type] => utility [patent_app_number] => 12/612399 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12048 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119534.pdf [firstpage_image] =>[orig_patent_app_number] => 12612399 [rel_patent_id] =>[rel_patent_doc_number] =>)